Australian Biotechnology News

Australian biotech market today 18.03.09

Alchemia, Avexa, Cytopia, Genera Biosystems, Universal Biosensors
Tags | Alchemia | Avexa | Cytopia | Genera Biosystems | Universal Biosensors

Pharma and biotech stocks were down slightly at 2.30pm today, on an up-and-down day for the All Ords.

Alchemia (ASX:ACL) is up yet again on the market today, trading at 32c and still basking in the washout from its partner filing a new drug application for generic fondaparinux.

Avexa (ASX:AVX) is down a touch from its recent gains, Biota (ASX:BTA) is up 5c to 61c and Cytopia (ASX:CYT) is up a cent.

Cochlear (ASX:COH) keeps rising and is now trading over $50 while CSL (ASX:CSL) is down a bit.

Newly listed Genera Biosystems (ASX:GBI) is active, up 2c, as is Halcygen (ASX:HGN).

Mesoblast (ASX:MSB) is down 2c, while Nanosonics (ASX:NAN) is up.

Universal Biosensors (ASX:UBI) is up 5c.

More about: Alchemia, Cochlear, CSL

Comments

Post new comment

The content of this field is kept private and will not be shown publicly.
Users posting comments agree to the Australian Life Scientist comments policy.
Login or register to link comments to your user profile, or you may also post a comment without being logged in.
Related Coverage